(Q39631387)

13 September 2017

title

Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study (English)

1 reference

chronic renal insufficiency

13 September 2017

1 reference

1 reference

Tsan Yang

1

1 reference

13 September 2017

Chi-Hong Chu

2

1 reference

13 September 2017

Chih-Hsung Hsu

3

1 reference

13 September 2017

Po-Chien Hsieh

4

1 reference

13 September 2017

Tieh-Chi Chung

5

1 reference

13 September 2017

Chyi-Huey Bai

6

1 reference

13 September 2017

San-Lin You

7

1 reference

13 September 2017

Lee-Ching Hwang

8

1 reference

13 September 2017

Chih-Ming Lin

9

1 reference

13 September 2017

Chien-An Sun

10

1 reference

13 September 2017

publication date

1 August 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

17

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

532-538

1 reference

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

The metabolic syndrome and chronic kidney disease in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Metabolic syndrome and chronic kidney disease in Okinawa, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Gm and Km allotypes in 74 Chinese populations: a hypothesis of the origin of the Chinese nation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Association between body-mass index and risk of death in more than 1 million Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Metabolic syndrome and kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

A prediction model for the risk of incident chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Metabolic syndrome: nature, therapeutic solutions and options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2012.01607.X

10.1111/J.1440-1797.2012.01607.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference